Jan 12, 2026
BioXcel Therapeutics Expands Leadership Team to Prepare for Launch of IGALMI® in the At-Home SettingVIEW RELEASE
Jan 07, 2026
BioXcel Therapeutics Planning to Submit sNDA This Month Seeking FDA Approval for At-Home Use of IGALMI®VIEW RELEASE
Dec 03, 2025
Award-Winning Journalist Anjalee Khemlani to Host Virtual Roundtable with Leading Medical Experts to Discuss Latest Developments in Treating Acute Agitation Related to Neuropsychiatric ConditionsVIEW RELEASE
Stock Information
BioXcel Therapeutics, Inc.
Jan 16, 2026 04:00 PM
MARKET/SYMBOL
Nasdaq:
BTAI
PRICE
1.84
CHANGE
-0.07 (-3.66%)
